vs

Side-by-side financial comparison of HARROW, INC. (HROW) and MERCANTILE BANK CORP (MBWM). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $67.6M, roughly 1.3× MERCANTILE BANK CORP). MERCANTILE BANK CORP runs the higher net margin — 33.6% vs 7.4%, a 26.1% gap on every dollar of revenue. Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 9.1%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...

HROW vs MBWM — Head-to-Head

Bigger by revenue
HROW
HROW
1.3× larger
HROW
$89.1M
$67.6M
MBWM
Higher net margin
MBWM
MBWM
26.1% more per $
MBWM
33.6%
7.4%
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
9.1%
MBWM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
MBWM
MBWM
Revenue
$89.1M
$67.6M
Net Profit
$6.6M
$22.7M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
7.4%
33.6%
Revenue YoY
33.3%
Net Profit YoY
-2.2%
16.1%
EPS (diluted)
$0.20
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
MBWM
MBWM
Q1 26
$67.6M
Q4 25
$89.1M
$62.1M
Q3 25
$71.6M
$62.4M
Q2 25
$63.7M
$60.9M
Q1 25
$47.8M
$57.3M
Q4 24
$66.8M
$58.5M
Q3 24
$49.3M
$58.0M
Q2 24
$48.9M
$56.8M
Net Profit
HROW
HROW
MBWM
MBWM
Q1 26
$22.7M
Q4 25
$6.6M
$22.8M
Q3 25
$1.0M
$23.8M
Q2 25
$5.0M
$22.6M
Q1 25
$-17.8M
$19.5M
Q4 24
$6.8M
$19.6M
Q3 24
$-4.2M
$19.6M
Q2 24
$-6.5M
$18.8M
Gross Margin
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Operating Margin
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
17.5%
42.0%
Q3 25
20.6%
44.0%
Q2 25
17.9%
42.6%
Q1 25
-23.5%
42.0%
Q4 24
19.3%
39.7%
Q3 24
2.7%
42.4%
Q2 24
3.1%
41.4%
Net Margin
HROW
HROW
MBWM
MBWM
Q1 26
33.6%
Q4 25
7.4%
36.8%
Q3 25
1.4%
38.1%
Q2 25
7.8%
37.1%
Q1 25
-37.2%
34.1%
Q4 24
10.1%
33.5%
Q3 24
-8.6%
33.8%
Q2 24
-13.2%
33.1%
EPS (diluted)
HROW
HROW
MBWM
MBWM
Q1 26
$1.32
Q4 25
$0.20
$1.41
Q3 25
$0.03
$1.46
Q2 25
$0.13
$1.39
Q1 25
$-0.50
$1.21
Q4 24
$0.19
$1.20
Q3 24
$-0.12
$1.22
Q2 24
$-0.18
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
MBWM
MBWM
Cash + ST InvestmentsLiquidity on hand
$72.9M
Total DebtLower is stronger
$250.0M
$1.5M
Stockholders' EquityBook value
$52.4M
$736.9M
Total Assets
$399.5M
$6.9B
Debt / EquityLower = less leverage
4.77×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
$72.9M
Q3 25
$74.3M
Q2 25
$53.0M
Q1 25
$66.7M
Q4 24
$47.2M
Q3 24
$72.6M
Q2 24
$71.0M
Total Debt
HROW
HROW
MBWM
MBWM
Q1 26
$1.5M
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Stockholders' Equity
HROW
HROW
MBWM
MBWM
Q1 26
$736.9M
Q4 25
$52.4M
$724.9M
Q3 25
$47.0M
$657.6M
Q2 25
$49.7M
$631.5M
Q1 25
$56.5M
$608.3M
Q4 24
$69.7M
$584.5M
Q3 24
$58.0M
$583.3M
Q2 24
$58.5M
$551.2M
Total Assets
HROW
HROW
MBWM
MBWM
Q1 26
$6.9B
Q4 25
$399.5M
$6.8B
Q3 25
$363.1M
$6.3B
Q2 25
$345.0M
$6.2B
Q1 25
$364.2M
$6.1B
Q4 24
$389.0M
$6.1B
Q3 24
$351.5M
$5.9B
Q2 24
$306.6M
$5.6B
Debt / Equity
HROW
HROW
MBWM
MBWM
Q1 26
0.00×
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
MBWM
MBWM
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
$8.4M
$18.0M
Q3 25
$16.6M
$23.1M
Q2 25
$-803.0K
$-7.8M
Q1 25
$19.7M
$-3.0M
Q4 24
$-17.8M
$101.1M
Q3 24
$3.0M
$-8.1M
Q2 24
$-2.7M
$9.1M
Free Cash Flow
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
FCF Margin
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Capex Intensity
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Cash Conversion
HROW
HROW
MBWM
MBWM
Q1 26
Q4 25
1.27×
0.79×
Q3 25
16.26×
0.97×
Q2 25
-0.16×
-0.35×
Q1 25
-0.15×
Q4 24
-2.62×
5.15×
Q3 24
-0.41×
Q2 24
0.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

MBWM
MBWM

Net Interest Income$55.9M83%
Noninterest Income$11.7M17%

Related Comparisons